almitrine has been researched along with Pneumonia, Viral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendjelid, K; Raphaël, G | 1 |
| Cardinale, M; Cotte, J; Cungi, PJ; Esnault, P; Goutorbe, P | 1 |
| Champigneulle, B; Delannoy, M; Lapoix, C; Losser, MR; Payen, D | 1 |
| Barthélémy, R; Blot, PL; Chousterman, BG; Gaugain, S; Gayat, E; Le Gall, A; Mayeur, C; Mebazaa, A; Morisson, L; Tiepolo, A | 1 |
| Bendjelid, K; Giraud, R; Von Düring, S | 1 |
5 other study(ies) available for almitrine and Pneumonia, Viral
| Article | Year |
|---|---|
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
Topics: Almitrine; Betacoronavirus; Capillary Leak Syndrome; Coronavirus Infections; COVID-19; Humans; Hypoxia; Lung; Lung Compliance; Pandemics; Patient Positioning; Pneumonia, Viral; Positive-Pressure Respiration; Pulmonary Circulation; Pulmonary Edema; Respiratory Mechanics; SARS-CoV-2; Switzerland; Tomography, X-Ray Computed; Vasoconstriction; Vasoconstrictor Agents | 2020 |
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Topics: Almitrine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Nitric Oxide; Oxygen Consumption; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Respiratory System Agents; Retrospective Studies; SARS-CoV-2; Vasoconstrictor Agents | 2020 |
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
Topics: Aged; Almitrine; Betacoronavirus; Case-Control Studies; Coronavirus Infections; COVID-19; Female; Humans; Hypoxia; Injections, Intravenous; Male; Middle Aged; Oxygen; Pandemics; Partial Pressure; Patient Positioning; Pneumonia, Viral; Prone Position; Respiratory Distress Syndrome; Respiratory System Agents; SARS-CoV-2 | 2020 |
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
Topics: Aged; Almitrine; Betacoronavirus; Blood Gas Analysis; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Female; Humans; Hypoxia; Male; Middle Aged; Oxygen; Oxygen Inhalation Therapy; Pandemics; Partial Pressure; Patient Positioning; Pneumonia, Viral; Positive-Pressure Respiration; Prone Position; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory System Agents; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2020 |
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Topics: Almitrine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hypoxia; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Respiratory System Agents; SARS-CoV-2 | 2020 |